Ambros Therapeutics
Latest round
- Series A
Last raised
- Dec 2025
Total raised
- $125M
Investors
- 8
About Ambros Therapeutics
Based in the US, Ambros Therapeutics, Inc.Ambros Therapeutics, Inc. is dedicated to advancing treatments for complex regional pain syndrome type 1.00 mn to date.Ambros Therapeutics specializes in the development of innovative therapeutics targeting complex regional pain syndrome type 1 (CRPS-1), a rare and debilitating metabolic bone disease characterized by severe pain and functional impairments following trauma. The company's primary product candidate, neridronate, is a third-generation bisphosphonate specifically designed to provide a disease-modifying therapy for patients suffering from warm CRPS-1. Neridronate operates by utilizing its unique binding characteristics to enhance safety and efficacy compared to traditional bisphosphonates.S. and EU. Revenue generation will be contingent upon successful clinical outcomes and subsequent regulatory approvals, enabling the company to transition to sales and marketing of neridronate. As the primary product candidate, neridronate is anticipated to be marketed directly to healthcare providers and institutions specializing in pain management and rehabilitation for CRPS-1 patients. The structure of future transactions is expected to be B2B, with potential distribution partnerships or collaborations with healthcare networks. The company is focused on expediting the development of new therapeutics and plans to expand its clinical trials into additional markets in Europe by 2026.
Who invested in Ambros Therapeutics
8 investors across 1 round
See all investors in Ambros Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 16, 2025
Amount
$125M
Investors
Questions about Ambros Therapeutics
Who invested in Ambros Therapeutics?
Ambros Therapeutics has 8 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ambros Therapeutics raised?
Ambros Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Ambros Therapeutics last raise money?
Ambros Therapeutics's most recent round on record is a Series A, in Dec 2025.
What does Ambros Therapeutics do?
Based in the US, Ambros Therapeutics, Inc.
Where is Ambros Therapeutics headquartered?
Ambros Therapeutics is headquartered in Irvine, US.
Which VCs invest in companies like Ambros Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Ambros Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Ambros Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.